Peacock R E, Hamsten A, Nilsson-Ehle P, Humphries S E
University College and Middlesex School of Medicine, Department of Medicine, Rayne Institute, London, UK.
Atherosclerosis. 1992 Dec;97(2-3):171-85. doi: 10.1016/0021-9150(92)90130-9.
Association studies were carried out on a sample of 87 patients from Sweden who had survived a myocardial infarction (MI) at a young age and 93 age-matched healthy individuals, to compare the impact of polymorphisms (PvuII, HindIII and Serine447-Stop) at the lipoprotein lipase (LPL) gene locus on among-individual differences in plasma lipid traits and progression of atherosclerosis. Significant linkage disequilibrium was detected between any two of these polymorphisms, with the Stop447 allele being only found on the same chromosome as the rare alleles (no cutting sites) of the PvuII and HindIII polymorphisms. In the healthy individuals, weak associations were found between genotypes of the HindIII polymorphism and triglycerides and the PvuII polymorphism and high density lipoprotein cholesterol explaining 7.4% and 5.6% of sample variance (P = 0.03 and 0.09), respectively. No associations were found between these traits and genotypes of the Serine447-Stop substitution, and thus it is unlikely to be the cause of the associations seen with the PvuII and HindIII polymorphisms even though it truncates the enzyme amino acid sequence. The presence of the rare allele, H-, of the HindIII polymorphism was associated with a smaller variance in triglycerides and both cholesterol and triglycerides in the very low density lipoprotein fraction, and with larger interdependent variation between these lipid traits, and also between LPL activity and these lipid traits. This implies that the H- allele, rather than the Stop447 allele, has the major impact on interdependence between traits which are directly or indirectly influenced by LPL activity. In the healthy individuals who were carriers of the apolipoprotein E2 allele, the inter-dependence between LPL activity and lipid traits was significantly smaller, and that between high density lipoprotein cholesterol and both cholesterol and triglycerides in the very low density lipoprotein fraction was much larger compared with non-carriers (P < 0.05). No significant associations were found between lipid traits or lipase activity and genotypes of the Serine447-Stop substitution. However, in the patients, global severity of coronary atherosclerosis at the first angiography was significantly associated with haplotype combinations of the HindIII and the Serine447-Stop polymorphisms, with the H-Stop haplotype being associated with the highest median score (P = 0.02). The data suggest that variation at the LPL gene locus is associated with a pleiotropic effect, that is not directly mediated by changes in lipids, on severity of coronary atherosclerosis.
对87名来自瑞典的年轻时曾患心肌梗死(MI)的患者以及93名年龄匹配的健康个体进行了关联研究,以比较脂蛋白脂肪酶(LPL)基因位点的多态性(PvuII、HindIII和丝氨酸447 - 终止密码子)对个体间血脂特征差异和动脉粥样硬化进展的影响。在这些多态性中的任意两个之间检测到显著的连锁不平衡,终止密码子447等位基因仅在与PvuII和HindIII多态性的罕见等位基因(无切割位点)位于同一条染色体上时才被发现。在健康个体中,发现HindIII多态性的基因型与甘油三酯之间以及PvuII多态性与高密度脂蛋白胆固醇之间存在弱关联,分别解释了样本方差的7.4%和5.6%(P = 0.03和0.09)。未发现这些性状与丝氨酸447 - 终止密码子替代的基因型之间存在关联,因此即使它截断了酶的氨基酸序列,也不太可能是与PvuII和HindIII多态性相关联的原因。HindIII多态性的罕见等位基因H - 的存在与甘油三酯的较小方差以及极低密度脂蛋白部分中的胆固醇和甘油三酯相关,并且与这些脂质性状之间以及LPL活性与这些脂质性状之间更大的相互依存变异相关。这意味着H - 等位基因而非终止密码子447等位基因对受LPL活性直接或间接影响的性状之间的相互依存性具有主要影响。在载脂蛋白E2等位基因携带者的健康个体中,与非携带者相比,LPL活性与脂质性状之间的相互依存性显著较小,而高密度脂蛋白胆固醇与极低密度脂蛋白部分中的胆固醇和甘油三酯之间的相互依存性则大得多(P < 0.05)。未发现脂质性状或脂肪酶活性与丝氨酸447 - 终止密码子替代的基因型之间存在显著关联。然而,在患者中,首次血管造影时冠状动脉粥样硬化的整体严重程度与HindIII和丝氨酸447 - 终止密码子多态性的单倍型组合显著相关,H - 终止密码子单倍型与最高中位数评分相关(P = 0.02)。数据表明,LPL基因位点的变异与对冠状动脉粥样硬化严重程度的多效性效应相关,这种效应不是直接由脂质变化介导的。